Skip to main content
Top
Published in: Nutrition Journal 1/2011

Open Access 01-12-2011 | Research

The role of salt abuse on risk for hypercalciuria

Authors: Patrícia CG Damasio, Carmen RPR Amaro, Natália B Cunha, Ana C Pichutte, José Goldberg, Carlos R Padovani, João L Amaro

Published in: Nutrition Journal | Issue 1/2011

Login to get access

Abstract

Background

Elevated sodium excretion in urine resulting from excessive sodium intake can lead to hypercalciuria and contribute to the formation of urinary stones. The aim of this study was to evaluate salt intake in patients with urinary lithiasis and idiopathic hypercalciuria (IH).

Methods

Between August 2007 and June 2008, 105 lithiasic patients were distributed into 2 groups: Group 1 (n = 55): patients with IH (urinary calcium excretion > 250 mg in women and 300 mg in men with normal serum calcium); Group 2 (n = 50): normocalciuric patients (NC). Inclusion criteria were: age over 18 years, normal renal function (creatinine clearance ≥ 60 ml/min), absent proteinuria and negative urinary culture. Pregnant women, patients with intestinal pathologies, chronic diarrhea or using corticoids were excluded. The protocol of metabolic investigation was based on non-consecutive collection of two 24-hour samples for dosages of: calcium, sodium, uric acid, citrate, oxalate, magnesium and urinary volume. Food intake was evaluated by the three-day dietary record quantitative method, and the Body Mass Index (BMI) was calculated and classified according to the World Health Organization (WHO). Sodium intake was evaluated based on 24-hour urinary sodium excretion.

Results

The distribution in both groups as regards mean age (42.11 ± 10.61 vs. 46.14 ± 11.52), weight (77.14 ± 16.03 vs. 75.99 ± 15.80), height (1.64 ± 0.10 vs. 1.64 ± plusorminus 0.08) and BMI (28.78 ± 5.81 vs. 28.07 ± 5.27) was homogeneous. Urinary excretion of calcium (433.33 ± 141.92 vs. 188.93 ± 53.09), sodium (280.08 ± 100.94 vs. 200.44.93 ± 65.81), uric acid (880.63 ± 281.50 vs. 646.74 ± 182.76) and magnesium (88.78 ± 37.53 vs. 64.34 ± 31.84) was significantly higher in the IH group (p < 0.05). There was no statistical difference in calcium intake between the groups, and there was significantly higher salt intake in patients with IH than in NC.

Conclusions

This study showed that salt intake was higher in patients with IH as compared to NC.
Literature
1.
go back to reference Heilberg IP, Schor N, Santos DR, Cheidde L, Noronha I, Duarte RJ, Brito AH, Mitre AI, Dénes FT, Barata HS: Diretrizes de litíase urinária da sociedade brasileira de nefrologia. J Bras Nefrol. 2002, 24: 2003-2007. Heilberg IP, Schor N, Santos DR, Cheidde L, Noronha I, Duarte RJ, Brito AH, Mitre AI, Dénes FT, Barata HS: Diretrizes de litíase urinária da sociedade brasileira de nefrologia. J Bras Nefrol. 2002, 24: 2003-2007.
2.
go back to reference Timio F, Kerry SM, Anson KM, Eastwood JB, Cappucio FP: Calcium urolithiasis, blood pressure and salt intake. Blood Press. 2003, 12: 122-127. 10.1080/08037050310001084.CrossRefPubMed Timio F, Kerry SM, Anson KM, Eastwood JB, Cappucio FP: Calcium urolithiasis, blood pressure and salt intake. Blood Press. 2003, 12: 122-127. 10.1080/08037050310001084.CrossRefPubMed
3.
go back to reference Amaro CRPR, Amaro JL, Goldberg J: Comportamento do magnésio urinário em pacientes com litíase renal. J Bras Nefrol. 2005, 27: 146-149. Amaro CRPR, Amaro JL, Goldberg J: Comportamento do magnésio urinário em pacientes com litíase renal. J Bras Nefrol. 2005, 27: 146-149.
4.
go back to reference Chula DC, Campos RP, Nascimento DE, Carvalho M: Caracterização clínica dos pacientes com hipercalciúria na nefrolitíase. J Bras Nefrol. 2006, 2: 72-76. Chula DC, Campos RP, Nascimento DE, Carvalho M: Caracterização clínica dos pacientes com hipercalciúria na nefrolitíase. J Bras Nefrol. 2006, 2: 72-76.
6.
go back to reference Baxmann AC, Marques NC, Menon VB, Heilberg IP: Nutrição do paciente com nefrolitíase. Nefrologia no consultório. Edited by: Barros E, Gonçalves LF. 2007, São Paulo: Artmed, 475-483. Baxmann AC, Marques NC, Menon VB, Heilberg IP: Nutrição do paciente com nefrolitíase. Nefrologia no consultório. Edited by: Barros E, Gonçalves LF. 2007, São Paulo: Artmed, 475-483.
7.
go back to reference Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron. 1976, 16: 31-41. 10.1159/000180580.CrossRefPubMed Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron. 1976, 16: 31-41. 10.1159/000180580.CrossRefPubMed
8.
go back to reference Burke BS: The dietary history as a tool in research. J Am Diet Assoc. 1947, 23: 1041-1046. Burke BS: The dietary history as a tool in research. J Am Diet Assoc. 1947, 23: 1041-1046.
9.
go back to reference Willett WC: Nutritional epidemiology. Modern epidemiology. Edited by: Rothman KJ, Greenland S. 1998, Philadelphia; Lippincott-Raven Publishers, 623-642. Willett WC: Nutritional epidemiology. Modern epidemiology. Edited by: Rothman KJ, Greenland S. 1998, Philadelphia; Lippincott-Raven Publishers, 623-642.
11.
go back to reference Zar JH: Biostatistical analysis. 1999, New Jersey: Prentice-Hall, 663-4 Zar JH: Biostatistical analysis. 1999, New Jersey: Prentice-Hall, 663-4
12.
go back to reference Hosmer DW, Lemeshow S: Applied survival analysis: regression modeling of time to event data. 1999, New York: John Willey & Sons, Inc, 299. Hosmer DW, Lemeshow S: Applied survival analysis: regression modeling of time to event data. 1999, New York: John Willey & Sons, Inc, 299.
14.
go back to reference Pérez FMA, Calderón JG, Herrero JV, Borros GC, Oltra AO, Bisono JRS: Epidemiología de la litiasis urinaria. Actas Urol Esp. 2001, 25: 341-349.CrossRef Pérez FMA, Calderón JG, Herrero JV, Borros GC, Oltra AO, Bisono JRS: Epidemiología de la litiasis urinaria. Actas Urol Esp. 2001, 25: 341-349.CrossRef
15.
go back to reference Ayusso LL, Schor N: Avaliação de pacientes com litíase renal em região de clima quente. J Bras Nefrol. 2001, 23: 205-212. Ayusso LL, Schor N: Avaliação de pacientes com litíase renal em região de clima quente. J Bras Nefrol. 2001, 23: 205-212.
16.
go back to reference Martín JAL, García JRR, Castro SN, Gómez IR, Rosado EF, Castelo LA: Factores de riesgo metabólico em urolitiasis cálcica según el sexo y edad de los pacientes. Actas Urol Esp. 2006, 26: 111-120.CrossRef Martín JAL, García JRR, Castro SN, Gómez IR, Rosado EF, Castelo LA: Factores de riesgo metabólico em urolitiasis cálcica según el sexo y edad de los pacientes. Actas Urol Esp. 2006, 26: 111-120.CrossRef
17.
go back to reference Amaro CRPR, Goldberg J, Amaro JL, Padovani CR: Metabolic Assessment in Patients with Urinary Lithiasis. Int Braz J Urol. 2005, 31: 29-33.CrossRefPubMed Amaro CRPR, Goldberg J, Amaro JL, Padovani CR: Metabolic Assessment in Patients with Urinary Lithiasis. Int Braz J Urol. 2005, 31: 29-33.CrossRefPubMed
18.
go back to reference Martini LA, Heilberg IP, Cuppari L, Medeiros FAM, Draibe AS, Ajzen H, Schor N: Dietary habits of calcium stone formers. Braz J Med Biol Res. 1993, 26: 805-812.PubMed Martini LA, Heilberg IP, Cuppari L, Medeiros FAM, Draibe AS, Ajzen H, Schor N: Dietary habits of calcium stone formers. Braz J Med Biol Res. 1993, 26: 805-812.PubMed
19.
go back to reference Siener R, Glatz S, Nicolay C, Hesse A: The role of overweight and obesity in calcium oxalate stone formation. Obes Res. 2004, 12: 106-113. 10.1038/oby.2004.14.CrossRefPubMed Siener R, Glatz S, Nicolay C, Hesse A: The role of overweight and obesity in calcium oxalate stone formation. Obes Res. 2004, 12: 106-113. 10.1038/oby.2004.14.CrossRefPubMed
20.
go back to reference Siener R, Schade N, Nicolay C, Unruh GE, Hesse A: The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol. 2005, 173: 1601-1605. 10.1097/01.ju.0000154626.16349.d3.CrossRefPubMed Siener R, Schade N, Nicolay C, Unruh GE, Hesse A: The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol. 2005, 173: 1601-1605. 10.1097/01.ju.0000154626.16349.d3.CrossRefPubMed
21.
go back to reference Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, Albala DM, Preminger GM: Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol. 2004, 172: 159-163. 10.1097/01.ju.0000128574.50588.97.CrossRefPubMed Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, Albala DM, Preminger GM: Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol. 2004, 172: 159-163. 10.1097/01.ju.0000128574.50588.97.CrossRefPubMed
22.
go back to reference Taylor EN, Stampfer MJ, Curhan GC: Obesity, weight gain and the risk of kidney stones. JAMA. 2005, 293: 455-462. 10.1001/jama.293.4.455.CrossRefPubMed Taylor EN, Stampfer MJ, Curhan GC: Obesity, weight gain and the risk of kidney stones. JAMA. 2005, 293: 455-462. 10.1001/jama.293.4.455.CrossRefPubMed
23.
go back to reference Timio F, Kerry SM, Anson KM, Eastwood JB, Cappuccio FP: Calcium urolithiasis, blood pressure and salt intake. Blood Press. 2003, 12: 122-127. 10.1080/08037050310001084.CrossRefPubMed Timio F, Kerry SM, Anson KM, Eastwood JB, Cappuccio FP: Calcium urolithiasis, blood pressure and salt intake. Blood Press. 2003, 12: 122-127. 10.1080/08037050310001084.CrossRefPubMed
24.
go back to reference Chula DC, Campos RP, Nascimento DE, Carvalho M: Caracterização clínica dos pacientes com hipercalciúria na nefrolitíase. J Bras Nefrol. 2006, 2: 72-76. Chula DC, Campos RP, Nascimento DE, Carvalho M: Caracterização clínica dos pacientes com hipercalciúria na nefrolitíase. J Bras Nefrol. 2006, 2: 72-76.
25.
go back to reference Massey LK, Whiting SJ: Dietary salt, urinary calcium and kidney stone risk. Nutr Rev. 1995, 53: 131-139. 10.1111/j.1753-4887.1995.tb01536.x.CrossRefPubMed Massey LK, Whiting SJ: Dietary salt, urinary calcium and kidney stone risk. Nutr Rev. 1995, 53: 131-139. 10.1111/j.1753-4887.1995.tb01536.x.CrossRefPubMed
26.
go back to reference Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A: Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002, 346: 77-84. 10.1056/NEJMoa010369.CrossRefPubMed Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A: Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002, 346: 77-84. 10.1056/NEJMoa010369.CrossRefPubMed
27.
go back to reference Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ: Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997, 126: 497-504.CrossRefPubMed Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ: Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997, 126: 497-504.CrossRefPubMed
28.
go back to reference Martini LA, Cuppari L, Colugnati FA, Sigulem DM, Szejnfeld VL, Schor N: High sodium chloride intake is associated with low bone density in calcium stone-forming patients. Clin Nephrol. 2000, 54: 85-93.PubMed Martini LA, Cuppari L, Colugnati FA, Sigulem DM, Szejnfeld VL, Schor N: High sodium chloride intake is associated with low bone density in calcium stone-forming patients. Clin Nephrol. 2000, 54: 85-93.PubMed
29.
go back to reference Moe OW, Preisig PA: Hypothesizing on the evolutionary origins of salt-induced hypercalciuria. Curr Opin Nephrol Hypertens. 2005, 14: 368-372. 10.1097/01.mnh.0000172724.29628.73.CrossRefPubMed Moe OW, Preisig PA: Hypothesizing on the evolutionary origins of salt-induced hypercalciuria. Curr Opin Nephrol Hypertens. 2005, 14: 368-372. 10.1097/01.mnh.0000172724.29628.73.CrossRefPubMed
30.
go back to reference Heilberg IP, Weisinger JR: Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens. 2006, 15: 394-402. 10.1097/01.mnh.0000232880.58340.0c.CrossRefPubMed Heilberg IP, Weisinger JR: Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens. 2006, 15: 394-402. 10.1097/01.mnh.0000232880.58340.0c.CrossRefPubMed
31.
go back to reference Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, Soldati L, Gambaro G, Maggiore U, Borghi L: Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. 2010, 91: 565-570. 10.3945/ajcn.2009.28614.CrossRefPubMed Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, Soldati L, Gambaro G, Maggiore U, Borghi L: Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. 2010, 91: 565-570. 10.3945/ajcn.2009.28614.CrossRefPubMed
32.
go back to reference Z Burtis WJ, Gay L, Insogna KL, Ellison A, Broadus AE: Dietary hypercalciuria in patients with calcium oxalate kidney stones. Am J Clin Nutr. 1994, 60: 424-429. Z Burtis WJ, Gay L, Insogna KL, Ellison A, Broadus AE: Dietary hypercalciuria in patients with calcium oxalate kidney stones. Am J Clin Nutr. 1994, 60: 424-429.
Metadata
Title
The role of salt abuse on risk for hypercalciuria
Authors
Patrícia CG Damasio
Carmen RPR Amaro
Natália B Cunha
Ana C Pichutte
José Goldberg
Carlos R Padovani
João L Amaro
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Nutrition Journal / Issue 1/2011
Electronic ISSN: 1475-2891
DOI
https://doi.org/10.1186/1475-2891-10-3

Other articles of this Issue 1/2011

Nutrition Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.